The in vivo therapeutic efficacy evaluated in tumor-bearing mice confirmed the therapeutic efficacy of anti-VCAM-1 and anti-IL4Rα aptamers that were conjugated to SPION as assessed by monitoring tumor growth and inhibition using noninvasive BLI and MRI. The gene discussed is IL4R; the disease is neoplasm.